Relationship Between ABO Blood group Phenotypes and nCOVID-19 Susceptibility – A Retrospective Observational Study

doi:10.21203/rs.3.rs-39611/v2

Background: Since the outbreak of coronavirus disease-19 research has been continued to explore multiple facets of the disease. The objective of the present study is to evaluate the relationship between blood group phenotypes and COVID-19 susceptibility.

Methods: In this hospital based, retrospective observational study 132 COVID-19 patients were enrolled from SMS Medical Hospital in Jaipur, India after receiving approval from the institutional ethics committee. The ABO, Rh and Kell blood group phenotypes along with demographic data of the patients were recorded. The observed proportions of ‘A’ , ‘B’, ‘AB’, ‘O’, ‘Rh’, and ‘Kell’ blood groups in COVID-19 patients were compared against the expected proportions (the null hypothesis) of the general population using Pearson’s chi-squared test and partition analysis.

Results: There were significant differences between observed and expected frequency for the ABO and Kell blood phenotypes. Further partition analysis of ABO phenotypes showed that the group ‘A’ phenotypes were more susceptible to COVID-19. The Kell negatives were also more susceptible. The blood groups ‘AB’, ‘B’, ‘O’, and ‘Rh’ showed no significant difference for susceptibility to COVID-19.

Conclusion: The study shows a relationship between ABO, Rh, and Kell blood groups and COVID-19 susceptibility. The application of these relationships in clinics should be explored in future studies.

Hematology

Infectious Diseases

Virology

ABO blood grouping

COVID-19 susceptibility

Kell blood group phenotypes

Pearson’s chi-squared test

Rh blood group phenotypes

According to the World Health Organisation report on 16 November 2020, there have been 54,075,995 confirmed cases of COVID-19, including 1,313,919 deaths globally.¹ The novel coronavirus 2019 (nCOVID-19) has spread beyond the boundaries of Wuhan, China across the world. Researchers in many countries are engaged in discovering associations between nCOVID-19 mortality, severity and susceptibility and, other attributes such as demographic, clinical, and laboratory findings.² A number of diseases have been found associated with various blood group phenotypes.

The ABO blood group antigens are widely distributed throughout the body along with the surface of red blood cells.³ The association of ABO groups with malaria, pancreatic cancer, duodenal ulcer and other diseases has been elucidated.^3-5 Microorganisms interact with antibodies against blood group antigens, including ABO, T and Kell systems.⁶The objective of this study was to evaluate the relationships between the ABO, Rh, and Kell blood group systems and susceptibility for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

A hospital-based, retrospective observational study was designed to evaluate ABO, Rh, and Kell blood group phenotypes and its relationship to susceptibility to SARS-CoV-2 infection. Laboratory confirmed, real-time reverse transcription polymerase chain reaction (RT-PCR) positive cases of COVID-19 numbering 132 were enrolled in the study from SMS Medical College and Hospitals in Jaipur (Rajasthan, India). The hospital provided medical care to patients of various states in North India, including Rajasthan, Harayana, Madhya Pradesh, Uttar Pradesh and Punjab.^{7, 8} The mean age of the participants was 36.68 years (SD = 17.87 years) and the men to women ratio was 8:3. The ABO, Rh, and Kell blood group phenotypes along with demographic data from the COVID-19 patients were collected from laboratory reports. The ABO, Rh (D antigen) and Kell phenotyping was carried out using fully automated solid phase red cell adherence (SPRCA) technology.⁹ The observed frequencies of the blood groups – ‘A’, ‘AB’, ‘B’ and ‘O’, ‘Rh positive’, ‘Rh negative’, ‘Kell positive’, and ‘Kell negative’ were calculated. The general (expected) proportions of the above blood groups were obtained from a study of the North Indian population.¹⁰ The expected proportions of ABO blood groups ‘A’, ‘AB’, ‘B’ and ‘O’ were 22.3 %, 8.9 %, 39.2 % and 29.6 %, respectively (Figure 1). Rh (D) phenotype were found positive in 93.8 % and negative in 6.2 %. For the Kell system, only 1.6 % were Kell positive, and the remaining were Kell negative. The expected frequencies of the blood group antigens were calculated by multiplying the total number of COVID-19 cases (n =132) with the general proportions of the respective blood groups (Table 1).

Statistical analysis

The observed frequency of blood group phenotypes of ABO, Rh and Kell system were compared against the expected population frequency using goodness of fit chi-square test. The further hypotheses were tested using partition analysis in case of the ABO system.¹¹ In order to find the effect of sample size on Type II error, post hoc power analysis was performed. The level of significance was considered at 5 %. Software used for the analysis was JASP (version 0.12.2) software and the Real Statistics package of MS Excel 2010.^{12, 13}

Ethical aspects

The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by Ethical Committee of the SMS Medical College, Jaipur (No.416 dated 26 Jun 2020) and individual consent for this retrospective analysis was waived.

The observed frequencies of ABO, Rh and Kell blood group phenotypes with 95 % confidence intervals were calculated (Figure 2). The comparison of the observed and expected frequencies of blood group phenotypes are shown in Figure 3.

Comparison of phenotypes of ABO Blood group system for COVID-19 susceptibility

The goodness of fit of observed and expected frequencies of the ABO blood groups were tested using Pearson’s chi-squared test (Table 1 and Figure 3).

There were significant differences between expected frequency and observed frequency in at least one of the blood group phenotypes (p = 0.013). The chi-squared test (χ2) does not reveal in which phenotype the difference actually exists. If the observed frequency is less than the expected frequency in one cell, it has to be more in one or the other cells because the total for both the observed and the expected frequencies is the same. The observed frequency was higher in blood group ‘A’ and lower in blood groups ‘AB’, ‘B’, and ‘O’. In order to confirm the difference in observed frequencies across blood groups, a partition analysis was performed. ABO blood group phenotypes were further divided into two sub-groups and two hypotheses were tested using the chi-squared test (Table 2). First, the observed and expected frequencies of blood groups ‘AB’, ‘B’, and ‘O’ were tested and no significant difference was found (p = 0.89). Second, the observed and expected frequencies of blood group ‘A’ and ‘non-A’ were tested and found to differ significantly (p = 0.001). Table 1 was partitioned based on those comparisons and the χ² was calculated (Table 2).

It should be noted that the value of χ_T² is very near to the sum of partitioned χ2 values, as shown in the equation:

χ_T² χ_I² +χ_II² = 0.23 + 10.59 = 10.82

It can be inferred from the above analysis that persons with blood group ‘A’ were more susceptible to COVID-19 than ‘non-A’ groups. Further, there were no significant relationships between the ‘AB’, ‘B’, and ‘O’ blood group phenotypes for susceptibility to COVID-19.

Comparison of Rh (D antigen) System for COVID-19 susceptibility

The observed and expected frequencies of Rh blood group phenotypes showed no statistically significant differences (p = 0.51) (Table 3).

Comparison of Kell antigen System for COVID-19 susceptibility

The observed and expected frequencies of Kell blood group phenotypes showed statistically significant differences (p < 0.001) (Table 4). The Kell negatives were more susceptible to COVID-19 infection compared to Kell positives.

The blood group antigens are an example of polymorphic traits inherited among individuals and populations. There are 34 recognised human blood groups and hundreds of individual blood group antigens and alleles. The variation in blood group system leads to variations in host susceptibility to many infections. Microorganisms interact with antibodies against blood group antigens, including ABO, T, and Kell systems.⁶ The blood group antigens of the H, ABO, Lewis, and historical ‘P’ blood groups contains small carbohydrate epitopes expressed as post-translational modifications on glycoproteins, mucins, and glycolipids. The ABO system (International Society of Blood Transfusion (ISBT) 001) contains two structurally related carbohydrate antigens, A and B. The O or H antigen is the biosynthetic precursor of A and B antigens and is classified as a separate blood group system (ISBT 018). All three antigens consist of 2 to 3 terminal oligosaccharides on glycoproteins and glycolipids.¹⁴ The varying rates of evolution of COVID-19 in two populations may be due to different gene frequency distributions of the blood group and may lead to differences in susceptibility to COVID-19.¹⁵

In order to evaluate the relationship between COVID-19 susceptibility and ABO blood group phenotypes, the null hypothesis H₀ that the blood group ratio A:B:AB:O in COVID-19 patients (observed frequency) is exactly the same as the general population (expected frequency) was tested, ie,

H₀ : A, AB, B, O are in the ratio 22 : 9 : 39 : 30

The results showed that H₀ was rejected(Table 1). The observed frequency of blood group ‘A’ was found to be higher than the expected frequency. Also, observed frequencies in other blood groups were lower than the expected frequencies. If observed frequency is higher than expected frequency in one cell, it has to be lower in one or more of the other cells since the total for both the observed and expected frequencies is the same. Thus, rejecting H₀ does not indicate which observed frequency is different from the expected one. In order to check whether the observed frequency of blood group ‘A’ is higher than the expected frequency further partition analysis was performed, and two more hypotheses were tested. The corresponding hypotheses were:

H_0A: AB, B, O are in the ratio 12 : 50 : 38.2

and

H_0B : A and non-A are in the ratio 22 : 78

The results showed there was no significant difference in observed ratios of AB : B : O blood groups when compared with expected (p = 0.89). However, there was a significant difference in the observed ratio A : non-A blood groups when compared with expected (p = 0.001) (Table 2). Thus, it was concluded that blood group ‘A’ was more susceptible to COVID-19 than ‘non-A’ groups. Further there were no significant relationships between the ‘AB’, ‘B’ and ‘O’ blood groups and COVID-19 susceptibility. The power of chi-squared tests for H₀, H_0A, and H_0B hypotheses were 79.5% , 6.7% and 90.2 %, respectively (25). No relationship was found between the Rh (D) antigen and SARS-CoV-2 susceptibility (Power = 10%). Also, the Kell negative appeared to be more susceptible to SARS-CoV-2 infection (Power = 99.8%). However, exact multinomial test seems to be more accurate. The power analysis showed that type II error was high in hypothesis H_0Aand H_Rh due to the small sample size and conclusions on significance could not be made.

Goker (2020) investigated ABO blood groups for 186 patients and reported that blood group A (57%) was the most frequently detected among the COVID-19 patients, followed by the blood group O (24.8 %). However, no association between blood group and clinical outcome was established. The Blood group A individuals were significantly higher in number with COVID-19 compared to controls (57 % vs 38 %, p < 0.001; OR: 2.1). While the frequency of blood group O was significantly lower in the COVID-19 patients, compared to the control group (24.8 % vs 37.2 %, p: 0.001; OR: 1.8).^[16] Likewise, a retrospective cohort study with 265 patients from the Central Hospital of Wuhan showed there is a higher proportion of patients infected with SARS-CoV-2 that have blood group ‘A’ than that in healthy controls (39.3 % vs. 32.3 %, p = 0.017), while the proportion of blood group ‘O’ in patients infected with SARS-CoV-2 was significantly lower than that in healthy controls (25.7 % vs. 33.8 %, p < 0.01).¹⁷ In other recent findings, Ziadi (2020) reported a decreased efficiency of adhesion of the Spike protein to the angiotensin converting enzyme 2 (ACE2) receptor by antibody A, as suggested in other studies. He further stated that a lower susceptibility of blood group ‘B’ and ‘O’ was the case, but it did not explain susceptibility of the ‘AB’ blood group without anti A and anti B in the blood serum.¹⁸

In contrast to the above, a study of 397 patients reported an increase in COVID-19 infection associated with the 'AB' blood group.¹⁹ However, the other findings of Abdollahi (2020) regarding no significant relationship between Rh phenotypes with COVID-19 susceptibility were consistent with the results presented in this study.¹⁹ A study using data from anti-A and anti-B antibodies rather than ABO blood group reported subjects with anti-A (ie, B and O blood groups) were significantly less susceptible to COVID-19 than those lacking anti-A regardless of group whereas there was no significant difference for anti-B in the serum.²⁰ Similarly, Guillon et al (2008) and Gustafsson et al (2005) argued that either a monoclonal anti-A antibody or natural plasma anti-A present in blood group ‘O’ specifically inhibited the SARS-CoV S protein/ACE2-dependent adhesion to ACE2-expressing cell lines. Therefore, ABO polymorphism could contribute to substantially reducing SARS-CoV transmission.^{21, 22} The results from Gustafsson et al (2005) confirmed that the glycans have more potential to carry variations than proteins and nucleic acids. The well-known example is polymorphic terminal glycosylation of the ABO blood group family of antigens. The association between infectious diseases and ABO antigens at mucosal surfaces leads to differential adherence of pathogens. Another way the blood group types might affect susceptibility is interaction with the coagulation system. Some factors like von Willebrand factor and factor VIII affect in vivo half-life and clearance of blood type antigens.²³

Similarly, Dai et al (2020) studied the interaction among COVID-19 cases, hypertension, and ABO blood grouping. They reported that hypertensive patients the renin-angiotensin-aldosterone system (RAS) was overexpressed due to inhibitors of angiotensin converting enzyme (ACE2). The expression of ACE2 receptors was upregulated in hypertensives. The ACE2 receptor was the primary entry site for SARS-CoV-2. Dai (2020) mentioned that the ABO blood group was associated with ACE activity and ACE inhibitors induced cough.

The GATC haplotype of the ABO gene polymorphism is prevalent among the non-O blood type patients and is positively associated with an ACE activity. Therefore, O blood type carriers have lower ACE levels and are less susceptible to COVID-19 infection.^[24] In a recent genome-wide association study between COVID-19 and disease severity (respiratory failure) 1,980 patients were included from Italy and Spain. Ellinghaus et al (2020) analysed 8,582,968 single-nucleotide polymorphisms and conducted a meta-analysis of the two case–control panels. They found significant cross-replicating associations with rs11385942 at locus 3p21.31 and with rs657152 at locus 9q34.2. The association signal at locus 9q34.2 coincided with the ABO blood group locus. In a blood-group–specific analysis, blood group A showed higher risk than in other blood groups (odds ratio, 1.45; 95% CI, 1.20 to 1.75) and blood group O showed a protective effect as compared to other blood groups (odds ratio, 0.65; 95% CI, 0.53 to 0.79).^[25]

There may be other mechanisms responsible for higher susceptibility of particular blood group phenotypes that require further studies.

The study shows a relationship between ABO blood grouping and COVID-19 susceptibility, with group A being more susceptible. The application of these relationship in clinical practice requires more exploratory studies.

Limitations of the study

The expected proportions used in this study lacked information regarding age and sex. Therefore, a multivariate analysis to adjust the effects of the two factors was not possible. However, this may not be necessary as since the distributions of blood group phenotypes were similar across age and gender. The sample size was not enough to provide powerful interpretation of Rh and Kell blood phenotypes and COVID-19 susceptibility.

As per the 'National Ethics Guidelines for Biomedical and Health Research' issued by Indian Medical Medical Research (ICMR) the consent of patients is waived (No 523 MC/EC/2020).

Conflicts of interest

None

Acknowledgements

None

ACE2: angiotensin converting enzyme inhibitors

ISBT: International society of blood transfusion

nCOVID-19: novel coronavirus disease-2019

p: p value

RT-PCR: reverse transcriptase polymer chain reaction

SARS-CoV-2: severe acute respiratory syndrome coronavirus 2

SD: standard deviation

SPRCA: solid phase red cell adherence

World Health Organization Coronavirus Disease (COVID-19) Dashboard. (Online). Available from: https://covid19.who.int/ (Accessed on 16 Nov 2020).
Bhandari S, Shaktawat AS, Tak A, Patel B, Shukla J, Singhal S, Gupta K, Gupta J, Kakkar S, Dube A. Logistic regression analysis to predict mortality risk in COVID-19 patients from routine hematologic parameters. Ibnosina J Med Biomed Sci (serial online) 2020 (cited 2020 Jun 30);12:123-9. Available from: http://www.ijmbs.org/text.asp?2020/12/2/123/288204
Wang D-S, Chen D-L, Ren C, Wang Z-Q, Qiu M-Z, Luo H-Y, et al. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer (Internet). Wiley; 2011 Nov 30;131(2):461–8. Available from: http://dx.doi.org/10.1002/ijc.26376
Clarke CA, Edwards JW, Haddock DRW, Howel-Evans AW, McConnell RB, Sheppard PM. ABO Blood Groups and Secretor Character in Duodenal Ulcer. BMJ (Internet). BMJ; 1956 Sep 29;2(4995):725–31. Available from: http://dx.doi.org/10.1136/bmj.2.4995.725
Häfner S. There will be blood. Microbes and Infection (Internet). Elsevier BV; 2020 Apr; Available from: http://dx.doi.org/10.1016/j.micinf.2020.04.008
Cooling L. Blood Groups in Infection and Host Susceptibility. Clinical Microbiology Reviews (Internet). American Society for Microbiology; 2015 Jun 17;28(3):801–70. Available from: http://dx.doi.org/10.1128/CMR.00109-14
Health Vision 2025, Medical Education Department, Government of Rajasthan (online) . Available from: https://education.rajasthan.gov.in/content/raj/education/medical-education-department/en/Vision2025.html# (Accessed on : 16 July 2020)
Kakkar S, Bhandari S, Shaktawat A, Sharma R, Dube A, Banerjee S, et al. A preliminary clinico-epidemiological portrayal of COVID-19 pandemic at a premier medical institution of North India. Annals of Thoracic Medicine (Internet). 2020;15(3):146. Available from: http://dx.doi.org/10.4103/atm.ATM_182_20
Immucor, Incorporation. Solid Phase Red Cell Adherence Assay Methods. (Online). Available from: http://www.immucor.com/en-us/Pages/Main-Page.aspx (Accessed 15 June 2020).
Deepak Kumar NG. Phenotype Prevalence of Blood Group Systems (ABO, Rh, Kell) in Voluntary, Healthy Donors-Experience of a Tertiary Care Hospital in Delhi, North India. J Blood Disord Transfus (Internet). OMICS Publishing Group; 2015;6(4). Available from: http://dx.doi.org/10.4172/2155-9864.1000297
Indrayan A, Malhotra RK. Medical biostatistics 4^th In Relationships : Quantitative Outcome. CRC Press, Taylor & Francis Group; 2018.pp 313-315.
JASP, Team. JASP (Version 0.12.2) (computer software). (Online). Available from: https://jasp-stats.org/ (Accessed 15 June 2020).

Zaiontz C. Real Statistics Using Excel, 2020 .Available from: real-statistics.com (Accessed on : 17 Jul 2020)

Cooling L. Carbohydrate blood groups. Rossi’s Principles of Transfusion Medicine (Internet). John Wiley & Sons, Ltd.; 2016. p. 159–75. Available from: http://dx.doi.org/10.1002/9781119013020.ch13
Bhandari S, Shaktawat AS, Tak A, Patel B, Gupta K, Gupta J, Kakkar S, Dube A. A multistate ecological study comparing evolution of cumulative cases (trends) in top eight COVID-19 hit Indian states with regression modeling. Int J Acad Med (serial online) 2020 (cited 2020 Jun 30);6:91-5. Available from:http://www.ijam-web.org/text.asp?2020/6/2/91/287965
Göker H, Aladağ Karakulak E, Demiroğlu H, et al. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome (published online ahead of print, 2020 Jun 4). Turk J Med Sci. 2020;10.3906/sag-2005-395. doi:10.3906/sag-2005-395
Li J, Wang X, Chen J, Cai Y, Deng A, Yang M. Association between ABO blood groups and risk of SARS‐CoV‐2 pneumonia. Br J Haematol (Internet). Wiley; 2020 May 26; Available from: http://dx.doi.org/10.1111/bjh.16797
Zaidi FZ, Zaidi ARZ, Abdullah SM, Zaidi SZA. COVID-19 and the ABO blood group connection. Transfus Apher Sci (Internet) 2020 Jun:102838. Available from: http://dx.doi.org/10.1016/j.transci.2020.102838
Abdollahi A, Mahmoudi-aliabadi M, Mehrtash V, Jafarzadeh B, Salehi M. The Novel Coronavirus SARS-CoV-2 Vulnerability Association with ABO/Rh Blood Types.
Iran J Pathol (Internet). Farname, Inc.; 2020 May 1;15(3):156–60. Available from: http://dx.doi.org/10.30699/ijp.2020.125135.2367
Gérard C, Maggipinto G, Minon JM. COVID-19 and ABO blood group: another viewpoint (published online ahead of print, 2020 May 26). Br J Haematol. 2020; doi:10.1111/bjh.16884
Guillon P, Clément M, Sébille V, Rivain J-G, Chou C-F, Ruvoën-Clouet N, et al. Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology (Internet). Oxford University Press (OUP); 2008 Sep 25;18(12):1085–93. Available from: http://dx.doi.org/10.1093/glycob/cwn093
Gustafsson K, Durrbach A, Seymour RM, Pomiankowski A. The Role of ABO Histo-Blood Group Antigens in Viral Infections. Trends Glycosci Glycotechnol (Internet). Forum: Carbohydrates Coming of Age; 2005;17(98):285–94. Available from: http://dx.doi.org/10.4052/tigg.17.285
Fernandez-Botran GR. ABO Blood Group Type and Susceptibility to COVID-19 Infection. Univ Louisville J Respir Infect 2020;4(1):11. Available from: https://ir.library.louisville.edu/jri/vol4/iss1/11/
Dai X. ABO blood group predisposes to COVID-19 severity and cardiovascular diseasesEur J Prev Cardiol (Internet). SAGE Publications; 2020 Apr 28;204748732092237. Available from: http://dx.doi.org/10.1177/2047487320922370
Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, et al. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. New England Journal of Medicine (Internet). 2020 Jun 17; Available from: http://dx.doi.org/10.1056/NEJMoa2020283

Table 1. The observed frequencies of ABO blood group phenotypes in 132 laboratory confirmed COVID-19 patients and expected frequency in general population (Garg et al., 2015).

	Blood Group Phenotype				Total
	A	AB	B	O	Total
Observed frequency	45	9	46	32	132
Expected frequency under H₀^*	29.43	11.74	51.74	39.07	132
χ_T²= 10.79 ; degree of freedom = 3 ; P value = 0.013

*H₀ is the null hypothesis, which have the expected proportions of A : AB : B : O phenotypes are 0.22 : 0.09 : 0.39 : 0.30, respectively.

Table 2. Partition of the observed frequencies of ABO blood group phenotypes in 132 laboratory confirmed COVID-19 patients and expected frequency in general population (Garg et al., 2015) (from Table 1) into two sections (Part I and II). Part I includes observed and expected frequency of AB and B blood groups, and part II include observed and expected frequency of ‘A’ and ‘O’ blood groups.

Part I
	Blood Group Phenotypes			Total
	AB	B	O	Total
Observed frequency	9	46	32	87
Expected frequency under H_0A^*	9.96	43.89	33.14	87
χ_I² = 0.23 ; degree of freedom = 2; P value = 0.89

Part II
	Blood Group Phenotypes			Total
	A	Non-A		Total
Observed frequency	45	87		132
Expected frequency under H_0B^**	29.43	102.57		132
χ_II² = 10.59 ; degree of freedom = 1; P value = 0.001

*H_0A is the null hypothesis with the expected proportions of AB : B: O phenotypes are 0.12 : 0.50 : 0.38, respectively.

**H_0B is the null hypothesis with the expected proportions of A : Non-A phenotypes are 0.22 : 0.78, respectively.

Table 3. The observed and expected frequencies of Rh antigen system in 132 laboratory confirmed COVID-19 patients.

	Rh D antigen System		Total
	Rh Positive	Rh Negative	Total
Observed frequency	122	10	132
Expected frequency under H_0Rh^*	123.81	8.19	132
χ_Rh² = 0.43 ; degree of freedom = 1; P value = 0.51

*H_0Rh is the null hypothesis with the expected proportions of Rh Positive : Rh Negative phenotypes are 0.94 : 0.06, respectively.

Table 4. The observed and expected frequencies of Kell antigen system in 132 laboratory confirmed COVID-19 patients.

	Kell antigen System		Total
	Kell Positive	Kell Negative	Total
Observed frequency	123	9	132
Expected frequency under H_0K^*	129.89	2.11	132
Χ_K² = 23.83 ; degree of freedom = 1; P value < 0.001

*H_0K is the null hypothesis with the expected proportions of Kell Positive : Kell Negative phenotypes are 0.98 : 0.02, respectively.

Relationship Between ABO Blood group Phenotypes and nCOVID-19 Susceptibility – A Retrospective Observational Study

Status:

Journal Publication

Version 2

Abstract

Figures

Introduction

Patients And Methods

Results

Discussion

Conclusion

Declarations

Abbreviations

References

Tables

Status:

Journal Publication

Version 2